Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic
Intravenous (IV) administration of antiviral monoclonal antibodies (mAbs) can be challenging, particularly during an ongoing epidemic, due to the considerable resources Equestrian Helmets required for performing infusions.An ebolavirus therapeutic administered via intramuscular (IM) injection would reduce the burdens associated with IV infusion and